Elunetirom

Elunetirom, also known by its developmental code names ABX-002 and MA-JD21, is a thyroid hormone receptor agonist which is under development for the treatment of major depressive disorder, bipolar depression, multiple sclerosis, and…

Uses your system voice; voice and rate in settings.

≈ 1 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Elunetirom, also known by its developmental code names ABX-002 and MA-JD21, is a thyroid hormone receptor agonist which is under development for the treatment of major depressive disorder, bipolar depression, multiple sclerosis, and adrenomyeloneuropathy. It is a prodrug of LL-340001 and acts as a potent, selective, and centrally penetrant agonist of the thyroid hormone receptor beta (TRβ).

The drug produces psychoplastogenic effects similar to those of brain-derived neurotrophic factor (BDNF) in rodents. In addition, it has been found to improve cognitive impairment caused by old age or scopolamine treatment in rodents. Elunetirom is under development by Autobahn Therapeutics.

As of December 2025, it is in phase 2 clinical trials for treatment of major depressive disorder and bipolar depression and is in the preclinical research stage of development for multiple sclerosis and adrenomyeloneuropathy.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1378206570 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001378206570 · captured 2026-10-03 · ledger · version history

Cite this page as: encyclopegia.org, “Elunetirom”, snapshot enwiki-001378206570. https://encyclopegia.org/a/elunetirom

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.